Log in  First Connection?

Oncology ImagingArchives

Whole-lesion-aware network based on freehand ultrasound video for breast cancer assessment: a prospective multicenter study

 Published on 04/07/2025 |  Original article (Full-text)  | Han Jie et al. | Cancer imaging 2025; 25(1): 75

Female breast cancer stands as a prominent contributor to cancer-related mortality among women globally [1]. In China, the landscape of cancer is in transition, breast cancer has shown a rapid increase in incidence rate among younger generation and an accelerated mortality rate in older populations [2]....

Multimodal imaging in cancer detection: the role of SPIONs and USPIONs as contrast agents for MRI, SPECT, and PET

 Published on 27/06/2025 |  Original article (Full-text)  | Zahra Shaghaghi et al. | Future Oncology 2025; aop:10.1080/14796694.2025.2520161

Nanomedicine has emerged as a transformative field in medical diagnostics, particularly in cancer detection. Superparamagnetic iron oxide nanoparticles (SPIONs) and ultrasmall superparamagnetic iron oxide nanoparticles (USPIONs) have garnered significant attention due to their remarkable properties,...

The role of multiparametric MRI in predicting lymphovascular invasion in breast cancer patients

 Published on 20/06/2025 |  Original article (Full-text)  | Jinhua Wang et al. | Future Oncology 2024; 20(35): 2747-56

This study aims to investigate the efficacy of multifactorial MRI in diagnosing breast cancer, specifically in the context of predicting lymphovascular invasion (LVI). Materials & methods: The patients were stratified into two groups: the primary group (100 patients) and...

Fluorodeoxyglucose positron emission tomography–computed tomography missed tibial metastasis in head and neck cancer: a case report and review of literature

 Published on 13/06/2025 |  Original article (Full-text)  | Movahedi Hamidreza et al. | Journal of Medical Case Reports 2025; 19(1): 263

Head and neck squamous cell carcinoma (HNSCC) is the seventh most common type of cancer. It is estimated that up to 40% of patients with HNSCC develop metastasis during the course of their disease [1, 2–3]. Lungs are the most frequent site of metastasis (60–70% of cases), followed by the...